Vanguard Group Inc Axogen, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,411,403 shares of AXGN stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,411,403

Previous 2,465,496 2.19%

Holding current value

$17.5 Million

Previous $16.8 Million 15.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$6.63 - $10.69 $358,636 - $578,254	-54,093 Reduced 2.19%	2,411,403 $19.5 Million
Q4 2023 Feb 14, 2024	SELL	$3.61 - $7.76 $47,020 - $101,074	-13,025 Reduced 0.53%	2,465,496 $16.8 Million
Q3 2023 Nov 14, 2023	BUY	$4.68 - $9.26 $264,588 - $523,523	56,536 Added 2.33%	2,478,521 $12.4 Million
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $572,415 - $699,020	67,343 Added 2.86%	2,421,985 $22.1 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $3.02 Million - $4.4 Million	401,473 Added 20.55%	2,354,642 $22.3 Million

Q4 2022 Feb 10, 2023	BUY	$9.44 - $13.09 $444,869 - $616,879	47,126 Added 2.47%	1,953,169 $19.5 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $128,196 - $192,925	15,749 Added 0.83%	1,906,043 $22.7 Million
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $228,370 - $326,710	-32,671 Reduced 1.7%	1,890,294 $15.5 Million
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $282,907 - $416,957	38,968 Added 2.07%	1,922,965 $15.3 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $209,369 - $380,672	23,792 Added 1.28%	1,883,997 $17.7 Million
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $1.17 Million - $1.66 Million	76,573 Added 4.29%	1,860,205 $29.4 Million
Q2 2021 Aug 13, 2021	BUY	$17.8 - $23.5 $31.7 Million - $41.9 Million	1,783,632 New	1,783,632 $38.5 Million

Others Institutions Holding AXGN

# of Institutions

125

Shares Held

34.1M

Call Options Held

80.7K

Put Options Held

3.3K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $306M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Axogen, Inc. Transaction History